Antiviral activity and safety of aplaviroc, a CCR5 antagonist, in combination with lopinavir/ritonavir in HIV‐infected, therapy‐naïve patients: results of the EPIC study (CCR100136)
Yeni, P, LaMarca, A, Berger, D, Cimoch, P, Lazzarin, A, Salvato, P, Smaill, FM, Teofilo, E, Madison, SJ, Nichols, WG, Adkison, KK, Bonny, T, Millard, J, McCarty, D
Published in HIV medicine (01.02.2009)
Published in HIV medicine (01.02.2009)
Get full text
Journal Article
Pharmacokinetics of oral ganciclovir alone and in combination with zidovudine, didanosine, and probenecid in HIV-infected subjects
Cimoch, P J, Lavelle, J, Pollard, R, Griffy, K G, Wong, R, Tarnowski, T L, Casserella, S, Jung, D
Published in Journal of acquired immune deficiency syndromes and human retrovirology (01.03.1998)
Published in Journal of acquired immune deficiency syndromes and human retrovirology (01.03.1998)
Get more information
Journal Article